BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tu LC, Foltz G, Lin E, Hood L, Tian Q. Targeting stem cells-clinical implications for cancer therapy. Curr Stem Cell Res Ther 2009;4:147-53. [PMID: 19442199 DOI: 10.2174/157488809788167373] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Bhoopathi P, Mannangatti P, Emdad L, Das SK, Fisher PB. The quest to develop an effective therapy for neuroblastoma. J Cell Physiol 2021. [PMID: 33834508 DOI: 10.1002/jcp.30384] [Reference Citation Analysis]
2 Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med 2010;5:121-43. [PMID: 20017699 DOI: 10.2217/rme.09.74] [Cited by in Crossref: 499] [Cited by in F6Publishing: 471] [Article Influence: 45.4] [Reference Citation Analysis]
3 Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12:767-775. [PMID: 23051844 DOI: 10.1038/nrc3368] [Cited by in Crossref: 422] [Cited by in F6Publishing: 395] [Article Influence: 46.9] [Reference Citation Analysis]
4 Mannoor K, Shen J, Liao J, Liu Z, Jiang F. Small nucleolar RNA signatures of lung tumor-initiating cells. Mol Cancer 2014;13:104. [PMID: 24886050 DOI: 10.1186/1476-4598-13-104] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
5 Islam F, Gopalan V, Wahab R, Smith RA, Lam AK. Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives. Crit Rev Oncol Hematol 2015;96:9-19. [PMID: 25913844 DOI: 10.1016/j.critrevonc.2015.04.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
6 Zhao L, Zhao Y, Bao Q, Niess H, Jauch K, Bruns C. Clinical Implication of Targeting of Cancer Stem Cells. Eur Surg Res 2012;49:8-15. [DOI: 10.1159/000339610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
7 Motohara T, Katabuchi H. Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance. Cancers (Basel) 2019;11:E907. [PMID: 31261739 DOI: 10.3390/cancers11070907] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
8 Deshmukh A, Deshpande K, Arfuso F, Newsholme P, Dharmarajan A. Cancer stem cell metabolism: a potential target for cancer therapy. Mol Cancer. 2016;15:69. [PMID: 27825361 DOI: 10.1186/s12943-016-0555-x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 16.2] [Reference Citation Analysis]
9 Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, Matsuno Y, Taketomi A. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687. [PMID: 25240521 DOI: 10.1186/1471-2407-14-687] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
10 Ahtiainen L, Mirantes C, Jahkola T, Escutenaire S, Diaconu I, Osterlund P, Kanerva A, Cerullo V, Hemminki A. Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus. PLoS One 2010;5:e13859. [PMID: 21079774 DOI: 10.1371/journal.pone.0013859] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, Kinnunen I, Ventelä S. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol 2011;47:510-6. [PMID: 21514878 DOI: 10.1016/j.oraloncology.2011.03.026] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
12 Bapat SA. Human ovarian cancer stem cells. Reproduction. 2010;140:33-41. [PMID: 20368192 DOI: 10.1530/rep-09-0389] [Cited by in Crossref: 69] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
13 Tan P. Divide and conquer: progress in the molecular stratification of cancer. Yonsei Med J 2009;50:464-73. [PMID: 19718393 DOI: 10.3349/ymj.2009.50.4.464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Yan X, Ma L, Yi D, Yoon JG, Diercks A, Foltz G, Price ND, Hood LE, Tian Q. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci USA. 2011;108:1591-1596. [PMID: 21220328 DOI: 10.1073/pnas.1018696108] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
15 Cerchia L, de Franciscis V. Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol. 2010;28:517-525. [PMID: 20719399 DOI: 10.1016/j.tibtech.2010.07.005] [Cited by in Crossref: 153] [Cited by in F6Publishing: 136] [Article Influence: 13.9] [Reference Citation Analysis]
16 Kamarajan P, Shin JM, Qian X, Matte B, Zhu JY, Kapila YL. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Cancer Med 2013;2:793-802. [PMID: 24403253 DOI: 10.1002/cam4.147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
17 Peng F, Li TT, Wang KL, Xiao GQ, Wang JH, Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, Cui B, Zheng FM, Wang HJ, Lam EW, Wang B, Xu J, Liu Q. H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis 2017;8:e2569. [PMID: 28102845 DOI: 10.1038/cddis.2016.438] [Cited by in Crossref: 111] [Cited by in F6Publishing: 124] [Article Influence: 27.8] [Reference Citation Analysis]
18 Shimura T, Noma N, Oikawa T, Ochiai Y, Kakuda S, Kuwahara Y, Takai Y, Takahashi A, Fukumoto M. Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells. Oncogenesis 2012;1:e12. [PMID: 23552696 DOI: 10.1038/oncsis.2012.12] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
19 Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol 2010;8:196-208. [PMID: 20691027 DOI: 10.1111/j.1476-5829.2010.00222.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
20 Gridley DS, Grover RS, Loredo LN, Wroe AJ, Slater JD. Proton-beam therapy for tumors of the CNS. Expert Rev Neurother 2010;10:319-30. [PMID: 20136386 DOI: 10.1586/ern.09.150] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
21 Patsalias A, Kozovska Z. Personalized medicine: Stem cells in colorectal cancer treatment. Biomed Pharmacother 2021;141:111821. [PMID: 34144456 DOI: 10.1016/j.biopha.2021.111821] [Reference Citation Analysis]
22 Kumar Mallik M. A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse. J Theor Biol 2010;266:496-503. [PMID: 20655317 DOI: 10.1016/j.jtbi.2010.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Talukdar S, Emdad L, Das S, Sarkar D, Fisher P. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Elsevier; 2016. pp. 159-91. [DOI: 10.1016/bs.acr.2016.04.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
24 Oh SJ, Noh KH, Lee YH, Hong SO, Song KH, Lee HJ, Kim S, Kim TM, Jeon JH, Seo JH, Kim DW, Kim TW. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells. Oncotarget 2015;6:40255-67. [PMID: 26517679 DOI: 10.18632/oncotarget.5434] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
25 Damek-Poprawa M, Volgina A, Korostoff J, Sollecito TP, Brose MS, O’Malley BW, Akintoye SO, DiRienzo JM. Targeted inhibition of CD133+ cells in oral cancer cell lines. J Dent Res. 2011;90:638-645. [PMID: 21220361 DOI: 10.1177/0022034510393511] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
26 Wicha MS. Stemming a tumor with a little miR. Nat Med 2011;17:162-4. [PMID: 21297608 DOI: 10.1038/nm0211-162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, Wicha MS, Nör JE. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010;70:9969-9978. [PMID: 21098716 DOI: 10.1158/0008-5472.can-10-1712] [Cited by in Crossref: 169] [Cited by in F6Publishing: 105] [Article Influence: 15.4] [Reference Citation Analysis]
28 Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX, Xue J, Xie D, Liu SR, Wu MC, Cheng SQ. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer 2010;102:1618-26. [PMID: 20461085 DOI: 10.1038/sj.bjc.6605689] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
29 Allegra A, Alonci A, Penna G, Innao V, Gerace D, Rotondo F, Musolino C. The cancer stem cell hypothesis: a guide to potential molecular targets. Cancer Invest 2014;32:470-95. [PMID: 25254602 DOI: 10.3109/07357907.2014.958231] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
30 Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther 2020;11:489. [PMID: 33208173 DOI: 10.1186/s13287-020-02018-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
31 Tomao F, Papa A, Strudel M, Rossi L, Lo Russo G, Benedetti Panici P, Ciabatta FR, Tomao S. Investigating molecular profiles of ovarian cancer: an update on cancer stem cells. J Cancer 2014;5:301-10. [PMID: 24723972 DOI: 10.7150/jca.8610] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
32 Aramini B, Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Morandi U, Dominici M, Haider KH. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021;12:230-50. [PMID: 33613850 DOI: 10.18632/oncotarget.27870] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Ko YH, Won HS, Jeon EK, Hong SH, Roh SY, Hong YS, Byun JH, Jung CK, Kang JH. Prognostic significance of CD44s expression in resected non-small cell lung cancer. BMC Cancer. 2011;11:340. [PMID: 21819617 DOI: 10.1186/1471-2407-11-340] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
34 Deshmukh A, Kumar S, Arfuso F, Newsholme P, Dharmarajan A. Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines. Sci Rep 2017;7:2256. [PMID: 28536422 DOI: 10.1038/s41598-017-02256-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
35 Rajasagi M, von Au A, Singh R, Hartmann N, Zöller M, Marhaba R. Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization. J Cell Mol Med 2010;14:1453-67. [PMID: 19765170 DOI: 10.1111/j.1582-4934.2009.00909.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
36 Murar M, Vaidya A. Cancer stem cell markers: premises and prospects. Biomark Med 2015;9:1331-42. [PMID: 26612591 DOI: 10.2217/bmm.15.85] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]